Emergent BioSolutions
EBS
#8041
Rank
$0.37 B
Marketcap
$7.20
Share price
-0.90%
Change (1 day)
18.53%
Change (1 year)

Emergent BioSolutions (EBS) - Net assets

Net assets on the balance sheet as of March 2026 : $0.52 Billion USD

According to Emergent BioSolutions 's latest financial reports the company has $0.52 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Emergent BioSolutions - Net assets on balance sheet (from 2004 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$$0.52 B8.24%
2024-12-31$$0.48 B-25.64%
2023-12-31$$0.64 B-53.21%
2022-12-31$$1.38 B-13.89%
2021-12-31$$1.61 B11.37%
2020-12-31$$1.44 B32.94%
2019-12-31$$1.08 B7.68%
2018-12-31$$1.01 B10.81%
2017-12-31$$0.91 B53.02%
2016-12-31$$0.59 B-9.67%
2015-12-31$$0.66 B19.31%
2014-12-31$$0.55 B13.09%
2013-12-31$$0.48 B10.64%
2012-12-31$$0.44 B6.1%
2011-12-31$$0.41 B11.56%
2010-12-31$$0.37 B53.21%
2009-12-31$$0.24 B22.31%
2008-12-31$$0.19 B16.47%
2007-12-31$$0.17 B23.61%
2006-12-31$$0.13 B131.8%
2005-12-31$$59.73 M160.3%
2004-12-31$$22.94 M
2002-12-31$$4.15 M-112.87%
2001-12-31$-$32.3 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
$90.40 B 17,182.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$45.93 B 8,680.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$23.07 B 4,310.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
$3.08 M-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
$0.15 B-71.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$0.45 B-12.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$8.23 B 1,473.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel